Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Cancer Drug Resistance -

Cancer Drug Resistance

Methods and Protocols

Marta Baiocchi (Herausgeber)

Buch | Hardcover
242 Seiten
2022 | 1st ed. 2022
Springer-Verlag New York Inc.
978-1-0716-2512-5 (ISBN)
CHF 299,55 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
This volume discusses the latest techniques used to identify cancer drug resistance determinants at the molecular, cellular, and functional levels. Chapters in this book cover up-to-date topics including tumor-microenvironment cell co-culture methods and microfluidics systems; workflows for functional assessment of drug resistance in vitro and in vivo; quantitative techniques for identifying quiescent blood-flow circulating cells; and single-cell characterization methods, such as mass cytometry. Written in the highly successful Methods in Molecular Biology series format, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and tips on troubleshooting and avoiding known pitfalls.

Cutting-edge and practical, Cancer Drug Resistance: Methods and Protocols is a valuable resource for all scientists and researchers who are looking to learn more about the latest developments in understanding and overcoming anticancer drug resistance.  

A 3D Biomimetic System for Testing Anticancer Drugs Sensitivity.- Patient-Derived Breast Cancer Tissue Cultures for Anti-Endocrine Drug Assays.- Co-Culture of Two Different Cell Lines in a Two-Layer Microfluidic Device.- Generation and Culture of Organotypic Breast Carcinoma Spheroids for the Study of Drug Response in a 3D Microfluidic Device.- A Methodological Workflow to Analyze Synthetic Lethality and Drug Synergism in Cancer Cells.- Establishment of In Vivo Acquired Resistance to Chemotherapy via Individual Dose Escalation Treatment Regime.- A Label Retaining System to Capture Slow Cycling Cancer Cells.- A Fast and Furious Liquid Biopsy Assay to Monitor Targeted Therapy Resistance.- Assessment of Tumor Heterogeneity in High-Grade Serous Ovarian Cancer: Mass Cytometry to Understand the Complex Tumor Biology.- Analysis of Transcriptomic Data Generated from Drug Treated Cancer Cell Line.- Simultaneous Mapping of Enhancers and Enhancer Rearrangements with Paired-End H3K27ac ChIP-seq.- Identification of Drug Resistance Mechanisms using Genome-Wide CRISPR-Cas9 Screens.- RNA Sequencing Data Analysis on the Maser Platform and the Tag-Count Comparison-Graphical User Interface.- Dissecting the Epigenomic Driving Drug Resistance by ATAC-Seq.- Polygenomic Interrogation of Drug Resistance Genes.- Analysis of ER-phagy in Cancer Drug Resistance.- Drug Target Prediction using Context-Specific Metabolic Models Reconstructed from rFastcormics.

Erscheinungsdatum
Reihe/Serie Methods in Molecular Biology ; 2535
Zusatzinfo 56 Illustrations, color; 19 Illustrations, black and white; XIII, 242 p. 75 illus., 56 illus. in color.
Verlagsort New York, NY
Sprache englisch
Maße 178 x 254 mm
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
Medizin / Pharmazie Studium
Schlagworte Determinants of resistance • Drug design and targeting • Drug resistant cells • early detection • Molecular analysis
ISBN-10 1-0716-2512-8 / 1071625128
ISBN-13 978-1-0716-2512-5 / 9781071625125
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Hannes Leischner

Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80
Resilienz innovativ stärken : ein Praxishandbuch

von Christa Diegelmann; Margarete Isermann; Tanja Zimmermann

Buch | Softcover (2023)
Kohlhammer (Verlag)
CHF 49,95